New combo painkiller for kids shows promise in hospital trial
NCT ID NCT07225634
First seen Nov 06, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study is testing an intravenous pain medicine called Combogesic® IV, which combines ibuprofen and acetaminophen, in children aged 2 to 17 with acute pain. The goal is to see how the body processes the drug and to confirm it is safe. Participants will receive the medicine every 6 hours as needed for up to 5 days, and blood samples will be taken to measure drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nemours Children's Health
Orlando, Florida, 32827, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.